Nadine, real BENLYSTA patient compensated by GSK

Prepare for Your Doctor’s Visit

Get the most out of your next appointment with a personalized discussion guide.

Answer the following questions to create a personalized discussion guide to bring to your next doctor’s visit, delivered right to your inbox.

All fields are required unless marked optional.

My symptoms

Which of these common lupus symptoms have you experienced? You’ll want to tell your doctor about any symptoms you’ve had, even if they haven’t been frequent or recent.

This is not a complete list of all possible symptoms, and BENLYSTA may not help with all of these symptoms. If you’re experiencing severe symptoms that require medical attention, please contact your physician immediately.

Select all that apply.

Please make a selection.

Have you experienced any of the following symptoms of lupus nephritis? (optional)

This is not a complete list of all possible symptoms, and BENLYSTA may not help with all of these symptoms. If you’re experiencing severe symptoms that require medical attention, please contact your physician immediately.

Select all that apply.

How would you describe the impact of these symptoms since your last appointment?

Please make a selection.

Select all that apply.

My treatment plan

How would you describe your experience with your lupus treatment?

Select one.

Please make a selection.

What are your goals for your treatment plan?

Select all that apply.

Please make a selection.

My questions about BENLYSTA

Whether you and your doctor have discussed BENLYSTA before, you may still have questions—get the answers you’re looking for.

Select the questions that you would like to include in your guide.

Please make a selection.

Email your personalized guide

Once you email yourself the completed guide, print it before your next appointment or pull it up on your mobile phone beforehand.

This field is required

This field is required

This field is required

By completing this form, you certify that you are at least 18 years old.

By providing your personal information, you are giving GSK and companies working with GSK permission to market to you across multiple channels, or contact you for market research, regarding the medical condition(s) in which you have expressed interest, as well as other health-related information from GSK.

For additional information regarding how GSK handles your information, please see our privacy notice.

Download a blank guide

Download a blank worksheet to fill out before your next appointment or share it with someone who may find it helpful.

Download Discussion Guide Worksheet

What is BENLYSTA & Safety Info
What is BENLYSTA?

For people ≥5 years with active SLE (lupus) or active lupus nephritis on other lupus medicines. Not for people with severe active central nervous system lupus. Serious side effects may include death, life-threatening brain infection (PML), and certain cancers. Tell your doctor ... [Continue Reading]

BENLYSTA is a prescription medicine used to treat people 5 years of age and older with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis (LN) (lupus-related kidney inflammation) who are receiving other lupus medicines. It is not known if BENLYSTA is safe/effective in people with severe active central nervous system lupus.

It is not known if BENLYSTA, given under the skin, is safe/effective in:

  • children with SLE under 5 years of age or weighing less than 33 lbs
  • children with LN under 18 years of age

It is not known if BENLYSTA, given in a vein (intravenously), is safe and effective in children less than 5 years of age.

Important Safety Information

Do not use BENLYSTA if you are allergic to belimumab or any ingredients in BENLYSTA.

The most important information about BENLYSTA 
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these may cause death.

  • Infections: fever, chills, pain, or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.